Literature DB >> 2211432

Influence of cefotaxime on microbial colonization resistance in healthy volunteers.

E J Vollaard1, H A Clasener, A J Janssen, H J Wynne.   

Abstract

The influence of cefotaxime 1000 mg given intravenously bd on microbial colonization resistance was investigated in six healthy volunteers. Administration of cefotaxime allowed colonization of the bowel by a resistant challenge strain of Enterobacter cloacae in all volunteers. The faecal concentration of aerobic flora increased significantly in five of six volunteers. In one the numbers of Gram-negative bacilli, enterococci and yeasts also increased. In the other four the faecal concentration of enterococci and yeasts increased, but Gram-negative bacilli did not rise above pre-treatment level. It is concluded that cefotaxime impairs colonization resistance, although to a variable degree. Therefore the term 'selective decontamination' is not fully justified for prophylactic regimens that include cefotaxime.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2211432     DOI: 10.1093/jac/26.1.117

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam.

Authors:  Y Carmeli; J Castro; G M Eliopoulos; M H Samore
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Effect of a selective decontamination of the digestive tract regimen including parenteral cefepime on establishment of intestinal colonization with vancomycin-resistant Enterococcus spp. and Klebsiella pneumoniae in mice.

Authors:  David L Paterson; Usha Stiefel; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

3.  Effectiveness of antibiotic prophylaxis in critically ill patients. Distinction must be made between tracheal inflammation and pneumonia.

Authors:  P J Sanderson
Journal:  BMJ       Date:  1998-11-28

Review 4.  The intestinal microbiota and susceptibility to infection in immunocompromised patients.

Authors:  Ying Taur; Eric G Pamer
Journal:  Curr Opin Infect Dis       Date:  2013-08       Impact factor: 4.915

Review 5.  Colonization resistance.

Authors:  E J Vollaard; H A Clasener
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

6.  Epidemiological impact of prolonged systematic use of topical SDD on bacterial colonization of the tracheobronchial tree and antibiotic resistance. A three year study.

Authors:  G Nardi; U Valentinis; A Proietti; A De Monte; A Di Silvestre; R Muzzi; R Peressutti; M G Troncon; F Giordano
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

7.  Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients.

Authors:  Robin F Benus; Hermie J Harmsen; Gjalt W Welling; Rob Spanjersberg; Jan G Zijlstra; John E Degener; Tjip S van der Werf
Journal:  Intensive Care Med       Date:  2010-03-16       Impact factor: 17.440

8.  Selective decontamination of the digestive tract: selectivity is not required.

Authors:  D F Zandstra; A J Petros; L Silvestri; M A de la Cal; N Taylor; V Damjanovic; H K F van Saene
Journal:  Intensive Care Med       Date:  2010-07-07       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.